Beneficial effects of dantrolene in the treatment of rhabdomyolysis as a potential late complication associated with COVID-19: a case report

Beneficial effects of dantrolene in the treatment of rhabdomyolysis as a potential late complication associated with COVID-19: a case report

Abstract Background Patients with severe COVID-19 have disorders of the respiratory, cardiovascular, coagulation, skeletal muscle, and central nervous systems. These systemic failures may be associated with cytokine release syndrome, characterized by hyperpyrexia, thrombocytopenia, hyperferritinemia...

Full description

Bibliographic Details
Main Authors: Nobutaka Chiba, Masakazu Matsuzaki, Takayuki Mawatari, Minori Mizuochi, Atsushi Sakurai, Kosaku Kinoshita
Format: Article
Language:English
Published: BMC 2021-02-01
Series:European Journal of Medical Research
Subjects:
COVID-19
Rhabdomyolysis
Hyperpyrexia
Dantrolene
Immune response
Online Access:https://doi.org/10.1186/s40001-021-00489-8

Internet

https://doi.org/10.1186/s40001-021-00489-8

Similar Items